China’s Harbin Pharmaceutical Group, which is controlled by CITIC Capital, has agreed to acquire a 40% stake in GNC Holdings for $300 million, becoming the largest shareholder in the US-based nutritional supplements retailer.
GNC will sell 299,950 new convertible preferred shares to Harbin Pharmaceutical at $1,000 apiece, according to a filing. The capital will be used to repay debt and for other corporate purposes. In addition,...
Baird Capital has acquired a minority stake in Nirvana Asia, a funeral services business that was privatized by CVC Capital Partners in 2016 in conjunction with the company’s founder.
Chinese PE firm Yunfeng Capital and Hong Kong-listed medical device manufacturer MicroPort Scientific Corporation will acquire US-listed LivaNova's cardiac rhythm management (CRM) business for $190 million in cash.
Emerging markets private capital fundraising – led by emerging Asia – reached its highest point since the before the global financial crisis in 2017, according to EMPEA, with capital dispersed more evenly across different strategies than ever before.
KKday, a Taiwan-based start-up that helps tourists find local activities, has secured $10.5 million Series B round of funding led by Japanese travel agent HIS, with participation from existing backer MindWorks Ventures.